Kurma Partners Scales Biotech Ambitions with Landmark €215M Venture Fund PARIS — In a decisive move to reshape the landscape of European medicine, VC firm Kurma Partners has officially closed a €215 million fund aimed at accelerating the development of transformative healthcare treatments. This new vehicle represents the firm’s fourth fund and stands as its … Read more
The survival rate for hardware innovation is staggering, with roughly 90% of hard tech startups collapsing under the weight of funding shortages and grueling R&D timelines. To stem this tide of failure, IEEE Entrepreneurship has launched the Hard Tech Venture Summits, a strategic initiative aimed at connecting visionary founders with the hard tech venture capital … Read more
Next-Gen Cancer Warfare: Sidewinder Therapeutics and Stipple Bio Secure Massive Funding to Revolutionize Antibody-Drug Conjugates NEW YORK — The landscape of precision oncology is shifting as two biotech trailblazers, Sidewinder Therapeutics and Stipple Bio, have each secured “mega-rounds” of financing. This influx of capital is earmarked for a singular, ambitious goal: perfecting the targeting mechanisms … Read more
Gilead Sciences Expands Autoimmune Disease Portfolio with $1.7 Billion Ouro Medicines Acquisition In a significant move to bolster its presence in the rapidly evolving field of autoimmune disease treatment, Gilead Sciences has announced the acquisition of Ouro Medicines, a privately held biotechnology company pioneering novel T cell engager therapies. The deal, valued at $1.7 billion, … Read more
Science Corporation Secures $230 Million Funding Amid FDA Review of Groundbreaking Retinal Implant Science Corporation, a pioneering biotechnology firm, announced today that it has successfully raised $230 million in a Series C funding round. This substantial investment arrives as the company anticipates a pivotal decision from the Food and Drug Administration (FDA) regarding PRIMA, its … Read more